GlaxoSmithKline PLC to Discuss Data Presented at ESMO Transcript
A very good day, and welcome to the GSK ESMO Investor Call. (Operator Instructions) I would also like to advise all parties this conference is being recorded. And now, I would like to hand over to Sarah Elton-Farr, Global Head of Investor Relations. Please proceed.
Thank you. Good evening, and good afternoon. Thank you for joining our ESMO Investor Call. You can view our slides on the Investor section of the GSK website.
Our speakers today are Dr. Hal Barron, Chief Scientific Officer and President of R&D; Dr. Antonio González-MartÃÂn, primary investigator on the PRIMA study and Head of Medical Oncology at the University Clinic of Navarra; Dr. Axel Hoos, Senior Vice President of Oncology R&D; and Luke Miels, President of Global Pharmaceuticals.
We have a broad team on the line for Q&A. Before we start, I would draw your attention to our cautionary statements on Slide 2. And with that, I will hand over to Hal.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
